Frequency and imaging features of abdominal immune-related adverse events in metastatic lung cancer patients treated with PD-1 inhibitor. [electronic resource]
Producer: 20200708Description: 1917-1927 p. digitalISSN:- 2366-0058
- Aged
- Antineoplastic Agents, Immunological -- adverse effects
- Biliary Tract Diseases -- chemically induced
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Female
- Fluorodeoxyglucose F18
- Gastrointestinal Diseases -- chemically induced
- Humans
- Immunotherapy -- adverse effects
- Lung Neoplasms -- drug therapy
- Male
- Nivolumab -- adverse effects
- Positron Emission Tomography Computed Tomography
- Radiography, Abdominal
- Radiopharmaceuticals
- Retrospective Studies
- Tomography, X-Ray Computed
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.